Overexpression of transforming growth factor alpha in psoriatic epidermis.
暂无分享,去创建一个
James T. Elder | R. Derynck | R. Coffey | J. Voorhees | M. Pittelkow | G. Fisher | L. Ellingsworth | G. Bennett | P. B. Lindquist
[1] M J Banda,et al. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. , 1988, Science.
[2] M. Sporn,et al. Induction of transforming growth factor-α in activated human alveolar macrophages , 1988, Cell.
[3] R. Coffey,et al. Growth modulation of mouse keratinocytes by transforming growth factors. , 1988, Cancer research.
[4] J. Schlessinger,et al. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. , 1988, Science.
[5] A. Gottlieb,et al. Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes , 1988, The Journal of experimental medicine.
[6] R. Akhurst,et al. Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis , 1988, Nature.
[7] E. Rosenberg,et al. The Koebner phenomenon and the microbial basis of psoriasis. , 1988, Journal of the American Academy of Dermatology.
[8] Yann Barrandon,et al. Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor-α and epidermal growth factor , 1987, Cell.
[9] M. Sporn,et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Barnhill,et al. Angiogenesis and the skin. , 1987, Journal of the American Academy of Dermatology.
[11] R. Derynck,et al. Different transforming growth factor-α species are derived from a glycosylated and palmitoylated transmembrane precursor , 1987, Cell.
[12] J. Voorhees,et al. Decreased protein kinase C activity in psoriatic versus normal epidermis. , 1987, The Journal of investigative dermatology.
[13] D. Goeddel,et al. Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors , 1987 .
[14] R. Tsien,et al. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor , 1987, Nature.
[15] Harold L. Moses,et al. Production and auto-induction of transforming growth factor-α in human keratinocytes , 1987, Nature.
[16] G. I. Bell,et al. Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. , 1986, Nucleic acids research.
[17] R. Derynck,et al. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.
[18] H. Moses,et al. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. , 1986, Cancer research.
[19] R. Evans,et al. Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms , 1986, Cell.
[20] L. Nanney,et al. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. , 1986, The Journal of investigative dermatology.
[21] G. Weinstein,et al. Cell kinetic basis for pathophysiology of psoriasis. , 1985, The Journal of investigative dermatology.
[22] Anita B. Roberts,et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells , 1985, Nature.
[23] C. Beaumont,et al. Accumulation of porphobilinogen deaminase, uroporphyrinogen decarboxylase, and alpha- and beta-globin mRNAs during differentiation of mouse erythroleukemic cells. Effects of succinylacetone. , 1985, The Journal of biological chemistry.
[24] J. Mansbridge,et al. Evidence for an alternative pathway of keratinocyte maturation in psoriasis from an antigen found in psoriatic but not normal epidermis. , 1984, The Journal of investigative dermatology.
[25] E. Chen,et al. Human transforming growth factor-α: Precursor structure and expression in E. coli , 1984, Cell.
[26] G. Chader,et al. Protein tyrosine kinase and protein phosphotyrosine phosphatase in normal and psoriatic skin. , 1984, Biochimica et biophysica acta.
[27] H. Valdimarsson,et al. T‐cell subpopulations in the blood and skin of patients with psoriasis , 1984, The British journal of dermatology.
[28] J. Massagué,et al. Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. , 1983, The Journal of biological chemistry.
[29] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[30] I. Braverman,et al. Role of the microcirculation in the treatment and pathogenesis of psoriasis. , 1982, The Journal of investigative dermatology.
[31] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[32] C. Squier. The permeability of keratinized and nonkeratinized oral epithelium to horseradish peroxidase. , 1973, Journal of ultrastructure research.
[33] P. Leder,et al. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Cohen,et al. Radioimmunoassay of epidermal growth factor. , 1972, Endocrinology.